StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes. They are being studied in early stage trials. On November 28, 2016, StemCells merged with Microbot Medical Ltd. and became Microbot Medical Inc.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| |
rdfs:comment
| - StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes. They are being studied in early stage trials. On November 28, 2016, StemCells merged with Microbot Medical Ltd. and became Microbot Medical Inc. (en)
|
foaf:name
| |
foaf:homepage
| |
name
| |
foaf:depiction
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
dbp:wikiPageUsesTemplate
| |
thumbnail
| |
homepage
| |
industry
| |
key people
| - Ian Massey (en)
- Irving L. Weissman, M.D. (en)
|
logo
| - StemCells, Inc. Logo 2.png (en)
|
type
| |
has abstract
| - StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes. They are being studied in early stage trials. On November 28, 2016, StemCells merged with Microbot Medical Ltd. and became Microbot Medical Inc. In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer. (en)
|
skos:closeMatch
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
industry
| |
key person
| |
type
| |
foaf:isPrimaryTopicOf
| |
is Link from a Wikipage to another Wikipage
of | |
is Wikipage redirect
of | |
is foaf:primaryTopic
of | |